Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...

The following is a summary of “Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study,” published in the January 2025 issue of Infectious Disease by ...

In early December 2024, a group of researchers published an article in the journal Science, entitled "A single mutation in ...

January 2025 – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading Pharmaceutical technology company, is proud to announces ...

Researchers at the University of Gothenburg, Sweden, in collaboration with colleagues in China, have discovered an ...

ANDERNACH, GERMANY - Newsaktuell - 14 January 2025 - LTS LOHMANN Therapie-Systeme AG (LTS), a leading <a target=_blank href= ...

Symptoms usually come on suddenly, according to the CDC, and can include fevers above 100.4 degrees F, dry cough, sore throat ...

The first inactivated influenza vaccine was monovalent (influenza ... viruses isolated during the 1900s); The subtype [16 possible hemagglutinin and 9 possible neuraminidase subtypes].

Recent headlines have stirred public concern about avian influenza, or bird flu, following a tragic death in Louisiana linked ...

Two months shy of the fifth anniversary of COVID-19 being declared a global pandemic, the US has recorded its first human ...

Fear of needles is a top reason for vaccine hesitancy and a major obstacle to getting vaccinated for many people around the ...

Phylowave reveals evolutionary dynamics in pathogens, identifying fitness-linked lineages and mutations, essential for ...